Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.44 |
| ▸ | MLNR known ✓ | O43193 | 1/20 | 0.44 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.44 |
| ▸ | ERBB2 known ✓ | P04626 | 1/20 | 0.44 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.44 |
| ▸ | ADRB1 known ✓ | P08588 | 1/20 | 0.44 |
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.44 |
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.44 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.44 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.44 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.44 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.44 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.44 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.44 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.44 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.44 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.44 |
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.44 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.44 |
| ▸ | ADRA1B known ✓ | P35368 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL7225810 | 1.00 | PARP14 (0.86) | PARP14BCHEHPGDSHRH1NPC1 | |
| Fumaric Acid SCHEMBL6631974 | 0.97 | PARP14 (0.81) | PARP14BCHEHPGDSHRH1NPC1 | |
| Fumaric Acid SCHEMBL6631979 | 0.97 | PARP14 (0.81) | PARP14BCHEHPGDSHRH1NPC1 | |
| SCHEMBL6633296 | 0.89 | PARP14 (0.93) | PARP14BCHEHPGDSHRH1NPC1 | |
| SCHEMBL7233408 | 0.88 | PARP14 (0.91) | PARP14BCHEHPGDSHRH1NPC1 | |
| Fumaric Acid SCHEMBL7004365 | 0.87 | PARP14 (0.65) | PARP14BCHEHPGDSHRH1NPC1 | |
| Fumaric Acid SCHEMBL7004363 | 0.87 | PARP14 (0.65) | PARP14BCHEHPGDSHRH1NPC1 | |
| Fumaric Acid SCHEMBL7227141 | 0.87 | PARP14 (0.65) | PARP14BCHEHPGDSLMNADRD2 | |
| Fumaric Acid SCHEMBL7227144 | 0.87 | PARP14 (0.65) | PARP14BCHEHPGDSLMNADRD2 | |
| Fumaric Acid SCHEMBL6623216 | 0.86 | PARP14 (0.63) | PARP14BCHEHPGDSHRH1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6610694-B1 | Suppressing histamine and/or eosinophil chemotaxis; treating allergic diseases | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-08-26 | — | — | US | disclosed |
| EP-1120418-A1 | FUSED PYRIDAZINE COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2001-08-01 | — | — | EP | disclosed |